Desvenlafaxine Extended Release Tablets 100Mg – DESQUIL 100 Tablets

DESQUIL 100 Tablets – Stronger SNRI Support for Lasting Emotional Balance.

DESQUIL 100 Tablets – Desvenlafaxine Extended Release Tablets 100 mg is a potent serotonin-norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder (MDD). Modulating neurotransmitter levels in the central nervous system helps restore emotional balance and improve motivation, concentration, and overall daily functioning.
The extended-release (ER) technology allows for controlled and sustained drug release, ensuring consistent plasma concentrations. This provides smoother symptom control and improves adherence to therapy by minimizing the need for multiple daily doses.

Key Benefits of Desvenlafaxine Extended Release Tablets – DESQUIL 100 Tablets
✅ Sustained Therapeutic Action – The ER formulation offers prolonged relief, reducing dosing frequency and stabilizing mood over 24 hours.
✅ Dual Neurotransmitter Modulation – Targets both serotonin and norepinephrine pathways, enhancing emotional resilience, energy, and cognitive performance.
✅ Improved Safety & Tolerability – Compared to older antidepressants, it carries a lower risk of sedation, weight gain, or sexual side effects—making it suitable for long-term treatment plans.

Recommended By Specialists:
👨‍⚕️ Psychiatrists: Primary prescribers for depression, anxiety spectrum disorders, and mood disturbances.
👨‍⚕️ Neurologists: Occasionally recommended for neuropathic pain and migraine-related conditions (off-label).
👨‍⚕️ General Physicians: Used for the initial management of depressive episodes where specialist referral is delayed.

INDICATIONS:
✅ Major Depressive Disorder (MDD)
✅ Generalized Anxiety Disorders
✅ Menopausal Vasomotor Symptoms (hot flashes, mood changes)
✅ Neuropathic Pain (off-label)
✅ Chronic Fatigue and Low Energy Associated with Depression